334 related articles for article (PubMed ID: 23322673)
1. In vitro and in vivo studies disclosed the depigmenting effects of gallic acid: a novel skin lightening agent for hyperpigmentary skin diseases.
Kumar KJ; Vani MG; Wang SY; Liao JW; Hsu LS; Yang HL; Hseu YC
Biofactors; 2013; 39(3):259-70. PubMed ID: 23322673
[TBL] [Abstract][Full Text] [Related]
2. Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells.
Jang JY; Kim HN; Kim YR; Choi WY; Choi YH; Shin HK; Choi BT
J Ethnopharmacol; 2011 Oct; 137(3):1207-14. PubMed ID: 21816215
[TBL] [Abstract][Full Text] [Related]
3. Dichloromethane fraction of Cimicifuga heracleifolia decreases the level of melanin synthesis by activating the ERK or AKT signaling pathway in B16F10 cells.
Jang JY; Lee JH; Kang BW; Chung KT; Choi YH; Choi BT
Exp Dermatol; 2009 Mar; 18(3):232-7. PubMed ID: 18803655
[TBL] [Abstract][Full Text] [Related]
4. A novel adamantyl benzylbenzamide derivative, AP736, suppresses melanogenesis through the inhibition of cAMP-PKA-CREB-activated microphthalmia-associated transcription factor and tyrosinase expression.
Lee CS; Jang WH; Park M; Jung K; Baek HS; Joo YH; Park YH; Lim KM
Exp Dermatol; 2013 Nov; 22(11):762-4. PubMed ID: 24107097
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of melanogenesis by gallic acid: possible involvement of the PI3K/Akt, MEK/ERK and Wnt/β-catenin signaling pathways in B16F10 cells.
Su TR; Lin JJ; Tsai CC; Huang TK; Yang ZY; Wu MO; Zheng YQ; Su CC; Wu YJ
Int J Mol Sci; 2013 Oct; 14(10):20443-58. PubMed ID: 24129178
[TBL] [Abstract][Full Text] [Related]
6. Anti-melanogenic effects of Aster spathulifolius extract in UVB-exposed C57BL/6J mice and B16F10 melanoma cells through the regulation of MAPK/ERK and AKT/GSK3β signalling.
Hwang GY; Choung SY
J Pharm Pharmacol; 2016 Apr; 68(4):503-13. PubMed ID: 26993057
[TBL] [Abstract][Full Text] [Related]
7. An inhibitory mechanism of action of a novel syringic-acid derivative on α-melanocyte-stimulating hormone (α-MSH)-induced melanogenesis.
Jeong YJ; Lee JY; Park J; Park SN
Life Sci; 2017 Dec; 191():52-58. PubMed ID: 28993145
[TBL] [Abstract][Full Text] [Related]
8. Interruption of p38
Kim SH; Lee J; Jung J; Kim GH; Yun CY; Jung SH; Hwang BY; Hong JT; Han SB; Jung JK; Kim Y
Int J Biol Sci; 2024; 20(5):1688-1704. PubMed ID: 38481807
[No Abstract] [Full Text] [Related]
9. Neural stem cells inhibit melanin production by activation of Wnt inhibitors.
Hwang I; Park JH; Park HS; Choi KA; Seol KC; Oh SI; Kang S; Hong S
J Dermatol Sci; 2013 Dec; 72(3):274-83. PubMed ID: 24016750
[TBL] [Abstract][Full Text] [Related]
10. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
11. Sesamol Inhibited Melanogenesis by Regulating Melanin-Related Signal Transduction in B16F10 Cells.
Wu PY; You YJ; Liu YJ; Hou CW; Wu CS; Wen KC; Lin CY; Chiang HM
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642438
[TBL] [Abstract][Full Text] [Related]
12. Sargaquinoic acid ameliorates hyperpigmentation through cAMP and ERK-mediated downregulation of MITF in α-MSH-stimulated B16F10 cells.
Azam MS; Kwon M; Choi J; Kim HR
Biomed Pharmacother; 2018 Aug; 104():582-589. PubMed ID: 29803170
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of melanin synthesis by haginin A and its application to in vivo lightening model.
Kim JH; Baek SH; Kim DH; Choi TY; Yoon TJ; Hwang JS; Kim MR; Kwon HJ; Lee CH
J Invest Dermatol; 2008 May; 128(5):1227-35. PubMed ID: 18037902
[TBL] [Abstract][Full Text] [Related]
14. cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.
Shin H; Hong SD; Roh E; Jung SH; Cho WJ; Park SH; Yoon DY; Ko SM; Hwang BY; Hong JT; Heo TY; Han SB; Kim Y
Br J Pharmacol; 2015 Jul; 172(13):3434-45. PubMed ID: 25766244
[TBL] [Abstract][Full Text] [Related]
15. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1.
Fang D; Setaluri V
Biochem Biophys Res Commun; 1999 Mar; 256(3):657-63. PubMed ID: 10080955
[TBL] [Abstract][Full Text] [Related]
16. p44/42 MAPK signaling is a prime target activated by phenylethyl resorcinol in its anti-melanogenic action.
Kang M; Park SH; Park SJ; Oh SW; Yoo JA; Kwon K; Kim J; Yu E; Cho JY; Lee J
Phytomedicine; 2019 May; 58():152877. PubMed ID: 30849679
[TBL] [Abstract][Full Text] [Related]
17. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
18. Fermented Viola mandshurica inhibits melanogenesis in B16 melanoma cells.
Kwak YJ; Kim KS; Kim KM; Yu HY; Chung E; Kim SJ; Cha JY; Lee YC; Lee JH
Biosci Biotechnol Biochem; 2011; 75(5):841-7. PubMed ID: 21597199
[TBL] [Abstract][Full Text] [Related]
19. Phytol suppresses melanogenesis through proteasomal degradation of MITF via the ROS-ERK signaling pathway.
Ko GA; Cho SK
Chem Biol Interact; 2018 Apr; 286():132-140. PubMed ID: 29486182
[TBL] [Abstract][Full Text] [Related]
20. Gamma-Irradiated Luteolin Inhibits 3-Isobutyl-1-Methylxanthine-Induced Melanogenesis Through the Regulation of CREB/MITF, PI3K/Akt, and ERK Pathways in B16BL6 Melanoma Cells.
Byun EB; Song HY; Mushtaq S; Kim HM; Kang JA; Yang MS; Sung NY; Jang BS; Byun EH
J Med Food; 2017 Aug; 20(8):812-819. PubMed ID: 28753056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
